person · Reporting owner
Kochevar Deborah Turner
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 13, 2024 | May 15, 2024 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 13, 2024 · Filed May 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,894 |
Reported balance
After 2024-05-13 transaction · row 1
1 source rowRow 1 · 2024-05-13 · Grant · Acquired 559 · Balance 7,894 F1: The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $228.41 · Expires 2034-05-13 | Direct | 1,311 |
Reported balance
After 2024-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-13 · Grant · Acquired 1,311 · Balance 1,311 F2: The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
F2: The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
Elanco Animal Health Inc
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 94,392 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 94,392 F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 20:45 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001448579-26-000002 · form4-05262026_080531.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,392 F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001448579-25-000005 · form4-12022025_101244.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,714 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:17 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028161 · form4-12032024_101201.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,400 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 13, 2024 Filed May 15, 2024 21:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,311 | $228.41 Strike: $228.41 | $299,445.51 |
DisclosureSEC source: 0001127602-24-015509 · form4.xml · derivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,311 Underlying: Common Stock · 1,311 shares Expires 2034-05-13 F2 · shares: The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 13, 2024 Filed May 15, 2024 21:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 559 | $228.41 | $127,681.19 |
DisclosureSEC source: 0001127602-24-015509 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,894 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015786 · form4-12042023_101227.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,231 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 15, 2023 Filed May 17, 2023 18:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,669 | $192.36 Strike: $192.36 | $321,048.84 |
DisclosureSEC source: 0001127602-23-015844 · form4.xml · derivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,669 Underlying: Common Stock · 1,669 shares Expires 2033-05-15 F2 · shares: The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 15, 2023 Filed May 17, 2023 18:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 664 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-015844 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,335 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011977 · form4-12022022_101229.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,857 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,582 | $222.31 Strike: $222.31 | $351,694.42 |
DisclosureSEC source: 0001127602-22-014408 · form4.xml · derivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,582 Underlying: Common Stock · 1,582 shares Expires 2032-05-11 F2 · shares: The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:20 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 575 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014408 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,671 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010524 · edgar.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,208 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 15:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,539 | $0.00 Strike: $164.24 | $0.00 |
DisclosureSEC source: 0001127602-21-023429 · form4.xml · derivative · entry 5 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,539 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 15:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5 | $407.29 | $2,036.43 |
DisclosureSEC source: 0001127602-21-023429 · form4.xml · nonDerivative · entry 4 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,096 Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 15:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,620 | $406.67 | $1,065,472.78 |
DisclosureSEC source: 0001127602-21-023429 · form4.xml · nonDerivative · entry 3 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F2 · price: This transaction was executed in multiple trades at prices ranging from $406.19 to $407.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 15:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 901 | $405.73 | $365,561.83 |
DisclosureSEC source: 0001127602-21-023429 · form4.xml · nonDerivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,721 F1 · price: This transaction was executed in multiple trades at prices ranging from $405.18 to $406.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 15:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,539 | $164.24 | $417,005.36 |
DisclosureSEC source: 0001127602-21-023429 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $342.55 | $0.00 |
DisclosureSEC source: 0001127602-21-016102 · form4.xml · derivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-07 F2 · shares: The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016102 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,083 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:19 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000509 · edgar.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,901 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,319 | $216.24 | $501,466.82 |
DisclosureSEC source: 0001127602-20-023318 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,728 F1 · price: This transaction was executed in multiple trades at prices ranging from $215.71 to $216.685. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2020 Filed May 12, 2020 17:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 2,539 | $0.00 Strike: $164.24 | $0.00 |
DisclosureSEC source: 0001127602-20-016232 · form4.xml · derivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 Underlying: Common Stock · 2,539 shares Expires 2030-05-11 F2 · derivative.exercise_date: The Stock Options become exercisable upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2020 Filed May 12, 2020 17:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 741 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016232 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,047 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:44 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000575 · edgar.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,016 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 18:20 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 1,000 | $27.95 | $27,950.00 |
DisclosureSEC source: 0000950138-19-000477 · edgar.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,783 Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019566 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,306 F1 · kind: Consists of 1,882 unvested restricted stock units that vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 21:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000248 · edgar.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783 F1 · price: Grant of deferred stock units to each of the non-employee members of the Issuer's Board of Directors, vesting three years from the date of grant. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $124.02 | $12,402.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 25 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,424 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 79 | $124.01 | $9,796.79 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 24 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,524 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $124.00 | $24,799.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 23 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,603 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $123.98 | $1,239.75 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 22 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,803 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 60 | $123.97 | $7,438.20 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 21 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,813 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $123.96 | $3,718.80 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 20 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,873 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.92 | $12,392.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 19 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,903 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $123.91 | $24,782.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 18 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,003 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $123.90 | $49,560.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 17 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,203 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $123.89 | $37,167.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 16 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,603 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $123.65 | $37,093.50 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 15 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,903 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.63 | $12,363.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 14 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,203 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.59 | $12,359.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 13 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 187 | $123.59 | $23,110.40 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 12 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,403 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $123.56 | $37,068.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 11 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,590 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $123.56 | $24,711.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 10 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,890 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.55 | $12,355.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 9 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,090 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.53 | $12,352.50 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 8 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,190 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $123.52 | $24,704.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 7 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,290 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $123.50 | $24,700.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 6 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,490 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.49 | $12,349.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 5 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,690 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.47 | $12,346.50 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 4 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,790 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $123.46 | $12,346.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 3 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,890 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.